Clinically relevant molecular subtypes in leiomyosarcoma

PURPOSE: Leiomyosarcoma (LMS) is a malignant neoplasm with smooth muscle differentiation. Little is known about its molecular heterogeneity and no targeted therapy currently exists for LMS. Recognition of different molecular subtypes is necessary to evaluate novel therapeutic options. In a previous...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Cancer Res
Prif Awduron: Guo, Xiangqian, Jo, Vickie Young, Mills, Anne M., Zhu, Shirley X., Lee, Cheng-Han, Espinosa, Inigo, Nucci, Marisa Rose, Varma, Sushama, Forgó, Erna, Hastie, Trevor, Anderson, Sharon, Ganjoo, Kristen, Beck, Andrew H., West, Robert B., Fletcher, Christopher, van de Rijn, Matt
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2015
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526352/
https://ncbi.nlm.nih.gov/pubmed/25896974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-3141
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg